Claire M. Hull

The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme

Andrew G. S. Warrilow, Claire M. Hull, Josie E. Parker et al. · Antimicrobial Agents and Chemotherapy · 2014 · 166 citations · Full text

Medicine, Microbiology, Pharmacology +17

Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation in <i>ERG11</i> and Exhibiting Cross-Resistance to Azoles and Amphotericin B

Claire M. Hull, Josie E. Parker, Oliver Bader et al. · Antimicrobial Agents and Chemotherapy · 2012 · 113 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Two Clinical Isolates of Candida glabrata Exhibiting Reduced Sensitivity to Amphotericin B Both Harbor Mutations in <i>ERG2</i>

Claire M. Hull, Oliver Bader, Josie E. Parker et al. · Antimicrobial Agents and Chemotherapy · 2012 · 89 citations · Full text

Life Sciences, Genetics, Microbiology +14

Clotrimazole as a Potent Agent for Treating the Oomycete Fish Pathogen Saprolegnia parasitica through Inhibition of Sterol 14α-Demethylase (CYP51)

Andrew G. S. Warrilow, Claire M. Hull, Nicola J. Rolley et al. · Applied and Environmental Microbiology · 2014 · 50 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Venous Thromboembolism and Marathon Athletes

Claire M. Hull, Julia A. Harris · Circulation · 2013 · 33 citations

Medicine, Hematology, Sports Medicine +8